Amgen, Hospira Battle Over Experts Ahead Of Patent Trial
By Vince Sullivan ( June 28, 2017, 6:23 PM EDT) -- Pharmaceutical company Amgen Inc. sparred Wednesday in Delaware federal court with competitor Hospira Inc. over expert reports each side is hoping to use at a September patent infringment trial on Hospira's efforts to produce a biosimilar version of Amgen's anti-anemia drug Epogen....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.